Kymera Therapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:KYMR) | MetaTrader

Tam grafiği aç Full chart

Haberler

Kymera atopik dermatit ilacı KT-621’in deneme verilerini sundu

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kymera, IBD ilaç adayı KT-579 için preklinik veri sundu

Kymera Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-05-04

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Kymera Therapeutics, Gilead anlaşması sonrası rapor açıklayacak

Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

FDA, Kymera’nın KT-621’ine astım için hızlı onay statüsü verdi

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

H.C. Wainwright, Kymera Therapeutics için al önerisini korudu